Stay updated on Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page's revision history now includes a new entry 'Revision: v3.5.5' and removes the previous 'Revision: v3.5.4' entry. This update represents a minor administrative change to the page metadata rather than user-facing content or functionality.
    Difference
    0.1%
    Check dated 2026-06-08T04:30:25.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    This page now shows Revision: v3.5.4, replacing the previous v3.5.3 revision. This indicates a small update to the page record without altering the study details or required actions for participants.
    Difference
    0.1%
    Check dated 2026-05-17T10:46:41.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    This change updates the ClinicalTrials.gov page revision version from v3.5.2 to v3.5.3, reflecting a site/software metadata update rather than a change to the underlying study record content.
    Difference
    0.1%
    Check dated 2026-04-25T18:35:38.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:25:47.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    - Version history updated: Revision v3.5.0 added; Revision v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-21T00:52:23.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Version bump from v3.4.2 to v3.4.3; study details and user-facing content remain the same.
    Difference
    0.1%
    Check dated 2026-03-06T18:16:21.000Z thumbnail image

Stay in the know with updates to Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page.